Colgate-Palmolive India Share Price: Analysts ne 'Sell' rating rakhi, Volume ki tension abhi bhi hai!

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorAarav Shah|Published at:
Colgate-Palmolive India Share Price: Analysts ne 'Sell' rating rakhi, Volume ki tension abhi bhi hai!
Overview

Brokers ka Colgate-Palmolive India ke stock par mood abhi bhi theek nahi hai. Q3 FY26 ke results bhi kuch khaas nahi rahe, isliye Emkay Global aur ICICI Securities ne 'Sell' rating pakdi hui hai. Company ki Net Sales bas **1.4%** badhi hai (**₹1,473 Cr**), aur Net Profit bhi flat raha (**₹324 Cr**). Analysts ko abhi bhi core oral care mein volume ki kami dikh rahi hai aur future growth ki visibility bhi clear nahi hai.

Brokers Q3 Results ke baad bhi 'Sell' Rating par kyun atke hain?

Asal baat ye hai ki Colgate-Palmolive India ke liye core oral care category, khaas kar ke mass segment mein volume badhana abhi bhi ek bada challenge bana hua hai. Company thodi revenue growth dikha rahi hai, lekin ye zyada tar cost cutting, premium products mix aur pricing strategies se aa rahi hai, asli demand increase se nahi. Isi wajah se, Emkay Global aur ICICI Securities jaise analysts ne apni 'Sell' rating maintain rakhi hai.

Valuation aur Future Growth par sawaal

ICICI Securities ne toh ₹1,800 ka target price diya hai, keh rahe hain ki stock ka valuation iski current growth ko reflect nahi karta. Unko lagta hai ki core oral care ke alawa koi bade growth engine nahi hain aur consumer demand mein recovery ke signs bhi nahi dikh rahe. Isliye, FY26-28 ke liye unhone earnings forecast bhi thoda kam kiya hai, revenue aur earnings CAGR 5% aur 4% ke aas-paas rahega.

Emkay Global ne bhi ₹2,000 ka target price rakha hai, jo unke 5-year average forward P/E se kam hai. Wo bhi category aur competition pressure ko lekar chintit hain. Unka kehna hai ki GST rate cuts se fayda ho sakta hai, par company ko premiumization aur innovation ke liye zyada advertising pe kharcha karna padega.

Q3 FY26 ke Numbers kya kehte hain?

Colgate-Palmolive India ne Q3 FY26 mein ₹1,473 Cr ki Net Sales report ki, jo pichle saal ke ₹1,452 Cr se bas 1.4% zyada hai. Net Profit ₹324 Cr par lagbhag flat raha, jo pichle saal bhi ₹323 Cr tha. Company ne 69.7% ke robust gross margins dikhaye hain, jo sequential improvement hai, aur premium segment mein investment bhi badhaya hai, jaise naya Colgate Visible White Purple Serum launch kiya hai.

Iske alawa, company ne new labor codes ke implementation aur GST changes ke wajah se potential impacts jaise exceptional expenses bhi bataye hain. Market mein Colgate-Palmolive India ki oral care sector mein position strong hai, competitors mein HUL, Dabur aur Patanjali hain.

Stock abhi kahan khada hai?

Sab kuch dekh kar, 30 January 2026 ko stock 0.28% gir kar ₹2,105.90 par trade kar raha tha. Stock ka P/E ratio lagbhag 44.4 tha aur Market Cap ₹57,439 Cr se ₹58,576 Cr ke beech thi. Analysts ka mannna hai ki Indian FMCG sector mein growth aane wali hai, par Colgate-Palmolive India ke liye challenge ye hai ki is market recovery aur premium strategies ko actual volume growth mein kaise badla jaaye. Jab tak broad-based demand nahi badhti, medium-term growth visibility constrained hi rahegi.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.